Sorafenib Tablet, Film Coated
Product Images NDC 0480-5425

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sorafenib (NDC 0480-5425). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

1 (Image 1)

1 (Image 1)
FDA Label Image

2 (Image 2)

2 (Image 2)
This is a result from a clinical trial of Sorafenib and placebo in patients with an unspecified medical condition. The trial involved 299 people who received Sorafenib and 303 who received a placebo. After measuring the time until the disease worsened or the patient died, the median time for those who received Sorafenib was 10.7 months, compared to 7.9 months for those who received placebo. The data is presented in a graph showing the percentage of patients still alive at each interval after the randomization. The graph shows that more patients taking Sorafenib survived throughout the trial compared to the placebo group.*
FDA Label Image

Figure 2 (Image 3)

Figure 2 (Image 3)
FDA Label Image

Figure 3 (Image 4)

Figure 3 (Image 4)
This appears to be a graph displaying the proportion of Progression-Free Survival for a certain treatment. It is not possible to determine any further information without additional context or data.*
FDA Label Image

1 (Image 5)

1 (Image 5)
This is a description of Teva tablets, USP containing 200mg of sorafenib tosylate, which is equivalent to 274mg of sorafenib, an anticancer drug. The package insert should be consulted for full prescribing information. The tablets should be stored in a dry place and kept out of the reach of children at 20° to 25°C (68°to 77°F) according to USP controlled room temperature. These tablets are manufactured for Teva Pharmaceuticals in Parsippany, NJ, and the product is intended for Rx only use. The provided NDC and GTIN codes can be used for identification purposes.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.